This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Norman R. C. Campbell | |
|---|---|
| Citizenship | Canadian |
| Occupation | Professor Emeritus |
| Awards | Order of Canada (2014) |
| Academic background | |
| Education | MD (1980), Memorial University of Newfoundland |
Norman R. C. Campbell is a Canadian professor emeritus at the University of Calgary. He has held professorships in medicine, community health sciences, physiology, and pharmacology. [1] In 2014, Campbell was appointed to the Order of Canada for his research and public health advocacy aimed at improving Canadians' well-being. [2]
Campbell received his medical degree from Memorial University of Newfoundland in 1978. He is an emeritus professor of medicine and holds a research chair at the University of Calgary, focusing on hypertension prevention and control. [3] [4] Campbell served as a consultant to the World Health Organization on nutrition and micronutrient issues, advising the World Bank and the Pan American Health Organization's HEARTS in the Americas Initiative on hypertension control, particularly in Cambodia, Mongolia, and Samoa. [5] His past affiliations include membership in the O'Brien Institute for Public Health and the Libin Cardiovascular Institute of Alberta. [6] He was also listed as a consultant for Resolve to Save Lives. [7]
During the 2000s, Campbell was president of Blood Pressure Canada and the Canadian Hypertension Society. In these roles, he contributed to the development of the Canadian Hypertension Recommendations – Control program [8] which produces annually updated, evidence-based recommendations and implementation strategies alongside a monitoring and evaluation process. [9] [10] The program has been credited with increasing hypertension control in Canada from 13% in the early 1990s to 68% in 2010. [11]
In 2006, he was involved in initiatives promoting sodium reduction and public awareness of hypertension through Blood Pressure Canada. As president of the Canadian Society for Clinical Pharmacology, he co-organized an international meeting of pharmacology organizations, which later developed into the Canadian Therapeutic Congress. He chaired the creation of a Pan-Canadian Framework for Hypertension Prevention and Control and supported the formation of Hypertension Canada through the unification of several national hypertension-focused organizations. Additionally, he has contributed to global position statements and advocacy campaigns related to dietary salt reduction and hypertension control.[ citation needed ] [12] [13]